Answers are grounded in this paper and cite their sources.
Hypervirulent Klebsiella pneumoniae (hvKP) is a severe threat to human health due to its capability to cause community-acquired infections in healthy individuals and its increasing resistance to antibiotic therapy. In this work, we developed a semisynthetic glycoconjugate vaccine for K2 serotype based on a single repeating unit structure through frameshift optimization, where the sequence of monosaccaride units in the oligosaccharide hapten was altered in order to mimic different digestion ways of the polysaccharide. The optimal tetrasaccharide hapten K2-FS2 showed good potential in vaccine development, eliciting a strong immune response and effectively protecting immunized mice from a lethal dose K2 serotype hvKP challenge in a sepsis model. Moreover, the vaccine candidate made from K2-FS2 was able to fully protect mice against the K64 serotype, which shares a disaccharide substructure with K2 CPS. The superiority of K2-FS2 as a hapten for the anti-KP vaccine covering both K2 and K64 serotypes, compared to the other two tetrasaccharides, highlights the importance of frameshift optimization in glycoconjugate vaccine development.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: